Medication, Sexual Health, Women's Health
From Symptoms to Solutions: New Strategies for Addressing Genitourinary Syndrome of Menopause
DURATION
30 min
PROFESSION
Physician, Specialist
# OF CREDITS
0.5
ACCREDITATION
Mainpro+
EXPIRY DATE
2026-03-28
Genitourinary syndrome of menopause (GSM) affects up to 80% of postmenopausal women, manifesting as a range of vulvovaginal symptoms that can severely impact quality of life, sexual health and overall well-being. Despite its prevalence, GSM and its associated symptoms are often underdiagnosed and undertreated. This program aims to bridge the knowledge gap by providing healthcare providers with a comprehensive understanding of the hormonal influences on vulvovaginal health and practical guidance on managing vulvovaginal symptoms through both non-hormonal and hormonal therapies, including new therapeutic options. By the end of this program, participants will be equipped with the tools necessary to improve patient outcomes through timely recognition and appropriate intervention.
This program has received financial support from Lupin Pharma Canada in the form of an unrestricted educational grant.
Faculty
- Jeanne Bouteaud, MD, FRCSC, MSc
- Jeffrey Habert, MD, CCFP, FCFP
- Jessica Chan, MD, CCFP
- Sofia Nastis, MD, CCFP
Learning objectives
Upon completion of this continuing education program, participants will be better able to:- Recognize signs and symptoms of genitourinary syndrome of menopause (GSM)
- Describe the roles of estrogens and androgens in vulvovaginal health
- Evaluate efficacy, effectiveness and safety data of recently Health Canada-approved GSM prescription therapy
- Apply evidence-based therapeutic strategies for GSM, including new therapeutic options
Accreditation
This self-learning program has been certified by the College of Family Physicians of Canada for up to 0.5 Mainpro+ credits.
Cert+ Program ID#: 203930
# of credits: 0.5 
Duration: 30 min FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
30 min
Duration
Physician, Specialist
Profession
0.5
# of credits
Learning Objectives
Upon completion of this continuing education program, participants will be better able to:
- Recognize signs and symptoms of genitourinary syndrome of menopause (GSM)
- Describe the roles of estrogens and androgens in vulvovaginal health
- Evaluate efficacy, effectiveness and safety data of recently Health Canada-approved GSM prescription therapy
- Apply evidence-based therapeutic strategies for GSM, including new therapeutic options
Mainpro+
ACCREDITATION
Medication, Sexual Health, Women's Health
Learning Category
Medication, Menopause, Women's Health
Topic
0
Price
2026-03-28
Expiry Date
CAN-eng
Region/Language
Course Description
Genitourinary syndrome of menopause (GSM) affects up to 80% of postmenopausal women, manifesting as a range of vulvovaginal symptoms that can severely impact quality of life, sexual health and overall well-being. Despite its prevalence, GSM and its associated symptoms are often underdiagnosed and undertreated. This program aims to bridge the knowledge gap by providing healthcare providers with a comprehensive understanding of the hormonal influences on vulvovaginal health and practical guidance on managing vulvovaginal symptoms through both non-hormonal and hormonal therapies, including new therapeutic options. By the end of this program, participants will be equipped with the tools necessary to improve patient outcomes through timely recognition and appropriate intervention.
This program has received financial support from Lupin Pharma Canada in the form of an unrestricted educational grant.
Faculty
- Jeanne Bouteaud, MD, FRCSC, MSc
- Jeffrey Habert, MD, CCFP, FCFP
- Jessica Chan, MD, CCFP
- Sofia Nastis, MD, CCFP
Accreditation
This self-learning program has been certified by the College of Family Physicians of Canada for up to 0.5 Mainpro+ credits.
Cert+ Program ID#: 203930
30 min
Duration
0
Price
0.5
# of credits
